Distributor inventory | Tablet
Glimepiride 0.5 mg + Metformin (strength unknown)
Type 2 diabetes mellitus (adult) to control high blood sugar when diet and exercise alone are not sufficient
Glimepiride (a sulfonylurea) increases insulin release from the pancreas and improves peripheral glucose utilization. Metformin (a biguanide) reduces glucose production in the liver and improves insulin sensitivity, lowering blood glucose without usually causing hypoglycaemia on its own.
Take by mouth as advised by doctor, usually once daily with or just after the first main meal to reduce stomach upset and risk of low sugar. Swallow tablet whole with water; do not crush/chew unless advised. Follow diet, exercise, and regular blood glucose monitoring.
Common side effects of GLIMIBRIT M 0.5MG TAB may include:
Risk of hypoglycaemia (more with missed meals, alcohol, strenuous exercise, elderly, kidney/liver impairment); metformin may rarely cause lactic acidosis—seek urgent care for severe weakness, rapid breathing, persistent vomiting, or abdominal pain. Use caution/avoid in significant renal impairment, severe liver disease, dehydration, severe infection, shock, or hypoxia; temporarily stop metformin before/after iodinated contrast or major surgery as advised. Monitor kidney function, HbA1c, and vitamin B12 (long-term metformin).
